JNJ - JOHNSON & JOHNSON
Close
166.2
0 0%
Share volume: 0
Last Updated: Tue 24 Dec 2024 06:00:07 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.51%
PREVIOUS CLOSE
CHG
CHG%
$166.20
-21.48
0.15%
View ratios
Fiscal Date | 2022-10-02 | 2023-01-01 | 2023-04-02 | 2023-07-02 | 2023-10-01 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
Report Date | 2022-10-27 | 2023-02-16 | 2023-04-28 | 2023-07-31 | 2023-10-27 | 2024-02-16 | 2024-05-01 | 2024-07-25 | |
Total revenue | 23.791 B | 23.706 B | 24.746 B | 25.530 B | 21.351 B | 13.532 B | 21.383 B | 22.447 B | |
Cost of revenue | 7.807 B | 7.765 B | 8.395 B | 8.212 B | 6.606 B | 3.340 B | 6.511 B | 6.869 B | |
Gross profit | 15.984 B | 15.941 B | 16.351 B | 17.318 B | 14.745 B | 10.192 B | 14.872 B | 15.578 B | |
-0.27% | 2.57% | 5.91% | -14.86% | -30.88% | 45.92% | 4.75% | |||
Operating expenses | 9.686 B | 10.353 B | 9.701 B | 10.494 B | 8.847 B | 7.555 B | 8.799 B | 9.121 B | |
Selling general and admin | 6.089 B | 6.512 B | 6.138 B | 6.665 B | 5.400 B | 3.309 B | 5.257 B | 5.681 B | |
Research and development | 3.597 B | 3.841 B | 3.563 B | 3.829 B | 3.447 B | 4.246 B | 3.542 B | 3.440 B | |
Total expenses | 17.493 B | 18.118 B | 18.096 B | 18.706 B | 15.453 B | 10.895 B | 15.310 B | 15.990 B | |
3.57% | -0.12% | 3.37% | -17.39% | -29.50% | 40.52% | 4.44% | |||
Operating income | 6.298 B | 5.588 B | 6.650 B | 6.824 B | 5.898 B | 2.637 B | 6.073 B | 6.457 B | |
Ebit | 6.298 B | 5.588 B | 6.650 B | 6.824 B | 5.898 B | 2.637 B | 6.073 B | 6.457 B | |
Pretax income | 5.822 B | 4.201 B | -737.000 M | 6.762 B | 5.217 B | 3.820 B | 3.714 B | 5.748 B | |
-27.84% | -117.54% | -1,017.50% | -22.85% | -26.78% | -2.77% | 54.77% | |||
Income tax | 1.364 B | 681.000 M | -669.000 M | 1.618 B | 908.000 M | -121.000 M | 459.000 M | 1.062 B | |
Net income basic | 4.458 B | 3.520 B | -68.000 M | 5.144 B | 26.028 B | 4.049 B | 3.255 B | 4.686 B | |
-21.04% | -101.93% | 7,664.71% | 405.99% | -84.44% | -19.61% | 43.96% | |||
Net income | 4.458 B | 3.520 B | -68.000 M | 5.144 B | 26.028 B | 4.049 B | 3.255 B | 4.686 B | |
-21.04% | -101.93% | 7,664.71% | 405.99% | -84.44% | -19.61% | 43.96% |